SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome

SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome

Purpose. To investigate in a pilot study of genetic polymorphisms in serotonin system influencing basal- and glucose-stimulated insulin secretion in women with polycystic ovary syndrome (PCOS). Methods. A cross-sectional study included 65 female patients with PCOS followed up at the endocrine outpat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Barbara Šenk, Katja Goričar, Nika Aleksandra Kravos, Mojca Jensterle Sever, Andrej Janež, Vita Dolžan
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2018/6130487
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome
by: Eva Drnovsek, et al.
Published: (2022-06-01)

Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome
by: Zahra Shaaban, et al.
Published: (2021-01-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Age, Body Mass Index, and Waist-to-Hip Ratio Related Changes in Insulin Secretion and Insulin Sensitivity in Women with Polycystic Ovary Syndrome: Minimal Model Analyses
by: Mirjana Šumarac-Dumanović, et al.
Published: (2022-01-01)

Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
by: Thanyarat Wongwananuruk, et al.
Published: (2012-01-01)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
by: Xu Boqun, et al.
Published: (2013-01-01)

Diagnosis and treatment of polycystic ovary syndrome
by: Ronelsys Martínez Martínez, et al.
Published: (2023-11-01)

Expression of miRNA and Occurrence of Distant Metastases in Patients with Hürthle Cell Carcinoma
by: Rok Petric, et al.
Published: (2016-01-01)

Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome
by: Aleksandra Biernacka-Bartnik, et al.
Published: (2022-01-01)

Ovulation Induction Techniques in Polycystic Ovary Syndrome - Systematic Review
by: Daria Michałka, et al.
Published: (2025-01-01)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
by: Pascal Froment, et al.
Published: (2006-01-01)

Polycystic Ovary Syndrome May Be an Autoimmune Disorder
by: Hifsa Mobeen, et al.
Published: (2016-01-01)

Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility
by: James Butterworth, et al.
Published: (2016-01-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
by: Andrijana Koceva, et al.
Published: (2025-01-01)

Extended High Frequency Audiometry in Polycystic Ovary Syndrome
by: Cuneyt Kucur, et al.
Published: (2013-01-01)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
by: Thozhukat Sathyapalan, et al.
Published: (2010-01-01)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
by: Carlos Moran, et al.
Published: (2012-01-01)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
by: Sweekruti Jena, et al.
Published: (2023-04-01)

Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome
by: Agnieszka Adamska, et al.
Published: (2017-01-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)

The Prevalence of Polycystic Ovary Syndrome in Women with Idiopathic Intracranial Hypertension
by: Inbal Avisar, et al.
Published: (2012-01-01)

Proposal for an Educational Program for the Prevention of Complications of Polycystic Ovary Syndrome
by: Edison Sotalin Nivela, et al.
Published: (2024-01-01)

Health-related Quality of Life in Women with Polycystic Ovary Syndrome
by: Belén Carazo Hernández, et al.
Published: (2014-04-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome
by: Thanyarat Wongwananuruk, et al.
Published: (2012-01-01)

Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
by: WANG Xueling, et al.
Published: (2025-02-01)

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome
by: Armaiti Parvez Mody, et al.
Published: (2025-01-01)

Evaluation of Retinal Changes in Women with Different Phenotypes of Polycystic Ovary Syndrome
by: Fatma Sumer, et al.
Published: (2025-01-01)

Polycystic ovary syndrome in a patient with type B insulin resistance syndrome can improve with glucocorticoid treatment: a case report and literature review
by: Tetsuhiro Watanabe, et al.
Published: (2023-10-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
by: Alexandre Connolly, et al.
Published: (2018-01-01)

Does Polycystic Ovary Syndrome Itself Have Additional Effect on Apelin Levels?
by: Dilek Benk Silfeler, et al.
Published: (2014-01-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
by: Xing Li, et al.
Published: (2022-01-01)

Ocular Surface Disease Severity in Polycystic Ovary Syndrome: is This Really Significant in Daily Life?
by: Demet Yabanoglu, et al.
Published: (2022-03-01)

Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
by: Mimouni, Nour El Houda, et al.
Published: (2024-04-01)

Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome
by: Mina Amiri, et al.
Published: (2025-02-01)

Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy
by: Eduardo Spinedi, et al.
Published: (2018-01-01)